What are the conditions for medical insurance reimbursement of crizotinib?

Crizotinib, a revolutionary targeted therapy designed to fight certain types of cancer. This drug has shown outstanding performance in the treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). At the same time, crizotinib also shows good therapeutic effects for ROS1-positive advanced non-small cell lung cancer.

As the first-generation targeted drug for lung cancer, crizotinib precisely acts on tumor cells and inhibits their growth and spread, thereby winning longer survival time and higher quality of life for patients. Not only that, the application of crizotinib also marks a big step in personalized medicine, making treatment more precise and effective. Of course, the indications need to be confirmed through genetic testing before using this drug to ensure that the drug can exert its maximum effect. Crizotinib medical insurance reimbursement conditions: limited to patients with anaplastic lymphoma kinase(ALK)-positive locally advanced or metastatic non-small cell lung cancer or patients with ROS1-positive advanced non-small cell lung cancer.

Currently, crizotinib has been launched in the domestic market. 250mg × 60 tablets are the common packaging. After being reimbursed by medical insurance, the cost is about 6,000 yuan. However, the specific price may vary depending on the region and hospital. It is recommended to consult the local hospital pharmacy directly. At the same time, Pfizer's original drug is sold overseas in 250 mg × 60 tablets, priced at around 10,000 yuan. In addition, there are many generic drugs of crizotinib on the market, mainly from Laos and Bangladesh, and the price is relatively low, about 2,600 yuan. In particular, the version produced by Lucius Pharmaceuticals in Laos is extremely cost-effective, with each box only costing 1,800 yuan. If patients want to know more details about generic drugs, it is recommended to contact a professional overseas medical consulting company.

More than just a drug, crizotinib is a symbol of medical progress that brings new hope to those suffering from serious illnesses. Its emergence has undoubtedly injected new vitality into the field of lung cancer treatment.